Stockwinners Market Radar for June 26, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:42 EDT Hershey cuts Facebook spending over 'volent and divisive speech' - Hershey said in a statement to media outlets: "We do not believe that Facebook is effectively managing violent and divisive speech on their platform. Despite repeated assertions by Facebook to take action, we have not seen meaningful change. Earlier this month we communicated to Facebook that we were unhappy with their stance on hate speech. We have now cut our spending on Facebook and their platforms, including Instagram, by a third for the remainder of the year. We are hopeful that Facebook will take action and make it a safe space for our consumers to communicate and gather. As a company, we stand for the values of togetherness and inclusion and we are resolute in our commitment to make a difference and be part of positive change." Reference Link

19:01 EDT Disney's 'Mulan' to open in theaters on August 21 - The Walt Disney Studios announced that Disney's "Mulan," a live-action epic directed by acclaimed filmmaker Niki Caro, will now debut in theaters on August 21. The film's release was previously delayed due to theater closures amid the COVID-19 pandemic and had been scheduled for release on July 24.

18:06 EDT Google sends users to news sites 24B times each month - Google said in a blog post that every month it sends Google users to news sites 24B times, providing an opportunity for publishers to grow their audiences and show Google's users ads or offers for subscriptions. Deloitte puts a value of each click for large publishers at roughly between 4c-7c. Google also noted that nearly all of its revenue comes not from news queries, but from queries with commercial intent, like someone searching for a new "toaster" and clicking on an ad. Google gets paid for search ads only when someone clicks on one. "As a company with a mission focused on making information universally accessible, we are invested in helping journalism not only survive, but thrive," Google said. "Alongside other companies, governments and civic society groups, we are playing our part in enabling a better future for news. And in light of some recent inaccurate claims about how Google works with the news industry and our value exchange with publishers, we felt it was important to set the record straight." Reference Link

17:34 EDT Churchill Downs reopens Presque Isle Downs in Pennsylvania - Churchill Downs announced the reopening of Presque Isle Downs & Casino in Erie, Pennsylvania. Live racing will resume without spectators on July 27 and will run until October 22, Mondays through Thursdays. Presque Isle will operate under specific capacity restrictions in compliance with state and local requirements. All CDI properties will implement and practice the "CDI 360 Degree Approach to Safety," which includes initiatives to facilitate social distancing, personal protection and enhanced cleaning. The company said there will be increased frequency of cleaning and sanitizing of all high-touch surfaces, including door handles, gaming machines, table games, handrails and elevator buttons. There will be mandatory temperature checks of all guests and team members upon entering the building. Installation of plexiglass or polycarbonate dividers will be put in areas of high touch transactions. There will also be increased placement of hand sanitizer dispensers and sanitary wipes throughout properties. Personal protective equipment will be provided to team members. The casino will be utilizing visual aids to assist with measuring social distancing. Capacity restrictions across all customer and team member areas, including casino floors and restaurants will be required as well as training for all team members on safety protocols.

17:24 EDT Northrop Grumman awarded $222.51M Air Force DOMES contract - Northrop Grumman has been awarded a $222.51M cost-plus-fixed-fee contract for the Defense Support Program, or DSP, operations, mission threat analysis and engineering sustainment, or DOMES. This contract provides on-orbit satellite and anomaly resolution support, root cause analysis, mission threat analysis, mission test bed and space awareness and global exploitation as key components of the lifetime extension of the DSP. Work is expected to be completed March 31, 2030. FY20 operations and maintenance funds in the amount of $18M is being obligated at the time of award. Space and Missile Systems Center is the contracting activity.

17:18 EDT Durect says Gilead terminates R&D agreement on SABER technology - DURECT (DRRX) announced that Gilead Sciences (GILD) has provided notice that, effective as of December 22, 2020, it is terminating the License Agreement dated July 19, 2019 and a related R&D agreement between Gilead and DURECT related to the development and commercialization of a long-acting injectable HIV investigational product utilizing DURECT's SABER technology. As a result of this termination, DURECT anticipates recognizing remaining deferred revenue of approximately $23.1M in Q2 of 2020, associated with the receipt of the upfront license and development milestone payment received in 2019 from Gilead. Therefore DURECT expects to recognize net income for the second quarter of 2020. Recognition of this deferred revenue is a non-cash financial item.

17:05 EDT Auryn Resources names Elizabeth Senez as interim CFO - Auryn Resources is pleased to announce the appointment of Elizabeth Senez as interim CFO of the company for a 14-month period effective July 1st. Senez is assuming the role while Auryn's CFO, Stacy Rowa, takes maternity leave starting on or about August 1st. Most recently, Senez was in the role of acting group treasurer for First Quantum Minerals Ltd., having moved through a range of progressively more senior roles in the UK and Panama during her eight years with the company.

16:29 EDT APEX Trading Group takes 1.27M stake in Superconductor Technologies - APEX Trading Group disclosed a stake of over 5% or 1.27M shares in Superconductor Technologies. The 13D filing does allow for activism.

16:16 EDT HP Inc. terminates shareholder rights plan - The Board of Directors of HP Inc. has approved an amendment to the company's shareholder rights plan to accelerate the expiration date of the plan to June 25, effectively terminating the plan as of that date. The limited duration rights plan was previously set to expire on February 20, 2021. Chip Bergh, Chair of HP's Board of Directors, said, "The shareholder rights plan was, by design, a temporary measure to protect the long-term interests of our shareholders. In reaching the decision to terminate the plan at this time, the Board took into careful consideration a variety of factors including the appropriateness of maintaining this plan when HP is no longer the subject of a hostile tender offer and corporate governance best practices."

16:04 EDT Texas Roadhouse expands board size to six, appoints Michael Crawford - On June 25, 2020, Texas Roadhouse (TXRH) board authorized an increase in the number of directors, which constitute the entire board, from five to six. On June 25, 2020, the board appointed Michael Crawford to fill the vacancy. Mr. Crawford was appointed as a director "because of his chief executive experience at Johnson Controls Hall of Fame Village, and his previous hospitality, international, and strategic planning experience with the Four Seasons Hotels and Resorts Company and the Walt Disney Company (DIS)."

15:33 EDT Phoenix Tree Holdings Limited (Class A ADS) trading halted, volatility trading pause

15:05 EDT Chiasma up 6% to $6.97 after receiving FDA approval for Mycapssa capsules

14:42 EDT IKONICS announces furloughs, additional cost cutting measures - IKONICS Corporation announced it will furlough approximately 40% of its 81 employee workforce until July 31. Employees were notified on June 25 and furloughed employees will continue to receive benefits. In addition to the furlough, IKONICS is suspending the company's contribution to its 401(k) retirement plan. These measures, together with previous actions that included a reduction of officer and board compensation, and the elimination of all non-essential expenditures will help to partially offset the impact of lost revenue from the COVID-19 pandemic.

14:25 EDT Facebook to seek to prohibit wider category of hateful content in ads - Facebook CEO Mark Zuckerberg said that the company is adopting some new policies to prohibit a wider category of hateful content in ads. Specifically, the company will expand ads policy to prohibit claims that people from a specific race, ethnicity, national origin, religious affiliation, sexual orientation, or immigration status are a particular threat to anyone else. Zuckerberg added that Facebook will start labeling content that Facebook finds newsworthy that might otherwise violate policies, since they may have "public interest value," such as certain posts or comments by politicians. Zuckerberg added that Facebook will take content down if it intimidates people to not vote. The CEO added that he is "committed" to making Facebook a place where people can use their voice, but he also "stands against hate." He noted that he is "optimistic" about making progress in combating these challenges. Comments taken from an update from the company's town hall broadcast on Facebook Live.

14:24 EDT Q and K International Group Ltd (ADS) trading resumes

14:19 EDT Facebook CEO says platform will label all posts about voting - Facebook CEO Mark Zuckerberg said that the platform will label all posts about voting and is adopting a policy of adapting a link to the platform's voting information center including posts that are relevant, including some from politicians. Zuckerberg said we are in a period of "confusion and fear" and therefor the company must take extra precautions to help everyone stay safe and informed, and use their voice to where it matters the most, which is voting. The CEO added that Facebook will ban posts making false claims related to voting and remove any threats of coordinated interference. Comments taken from an update from the company's town hall broadcast on Facebook Live.

14:07 EDT Pfenex announces 'positive' European CHMP opinion for PF708 - Pfenex (PFNX) announced the achievement of several significant milestones across their business portfolio. Theramex, the European commercialization partner for Pfenex and Adalvo, received a positive opinion for PF708 from the Committee for Medicinal Products for Human Use of the European Medicines Agency. Additionally, Adalvo recently entered into a commercialization agreement with a multinational pharmaceutical company to commercialize PF708, upon receipt of marketing authorization, in certain countries in Latin America. Merck (MRK) recently announced that V114, its investigational 15-valent pneumococcal conjugate vaccine met safety and immunogenicity objectives in initial Phase 3 studies in adults. Also, Serum Institute of India announced its first supply agreement with UNICEF for Pneumosil, a 10-valent pneumococcal vaccine developed to address pneumococcal infection in low- and middle-income countries. Both V114 and Pneumosil contain CRM197 produced via license agreements to the Pfenex Expression Technology, pursuant to which Pfenex may earn development milestone payments and royalties on net product sales. "This is an exciting time for Pfenex as we continue to achieve meaningful clinical, regulatory and commercial milestones across our pipeline, highlighted today by the positive opinion on Livogiva from the CHMP and the announcement of positive results in two of Merck's Phase 3 studies for the Merck V114 vaccine," said Pfenex CEO Eef Schimmelpennink. "Over the past few years, we have had a relentless, laser like focus on our core portfolio and we believe those efforts are paying off."

13:42 EDT Caesars' Atlantic City resorts to reopen July 3 - In anticipation of New Jersey Governor Phil Murphy's order authorizing the reopening of Atlantic City casinos, Bally's, Caesars, and Harrah's Resort will re-open on Friday, July 3rd, just in time for the Fourth of July holiday, Caesars Entertainment said in a statement. "We are thrilled to welcome back both our team members and customers to Bally's, Caesars, and Harrah's Resort and look forward to creating more memories together," said Ron Baumann, Regional President for Caesars Entertainment, Atlantic City region. "The well-being of our team members and guests is important to us, and we are focused on enhancing our health and safety protocols to provide an enjoyable guest experience that emphasizes social distancing and cleanliness."

13:16 EDT Caesars announces FTC clearance of merger with Eldorado Resorts - Caesars Entertainment (CZR) announced that the Federal Trade Commission has accepted a proposed consent order, which concludes the FTC's Hart-Scott-Rodino review of Caesars' pending merger with Eldorado Resorts (ERI). The FTC's acceptance of the consent order satisfies all required antitrust clearances for the merger, Caesars stated. "We are pleased that the FTC's approval of our planned merger with Eldorado paves the way for securing the remaining consents and approvals from regulators in Indiana, Nevada and New Jersey. All of us at Caesars are committed to completing the merger, which is expected to create the largest U.S. gaming company," said Tony Rodio, CEO of Caesars Entertainment.

13:04 EDT Eldorado announces FTC clearance of merger with Caesars - Eldorado Resorts (ERI) announced that the Federal Trade Commission has accepted a proposed consent order, which concludes the FTC's Hart-Scott-Rodino review of Eldorado's pending merger with Caesars Entertainment (CZR). The FTC's acceptance of the consent order satisfies all required antitrust clearances for the merger, the company said. Consummation of the merger remains subject to the satisfaction of other closing conditions, including receipt of all consents and approvals from the Nevada Gaming Control Board, Nevada Gaming Commission, New Jersey Casino Control Commission, Indiana Gaming Commission and Indiana Horse Racing Commission. "We are delighted to announce the FTC's approval of our planned Merger with Caesars, which is expected to create the largest owner and operator of U.S. gaming assets. We look forward to completing the Merger, subject to receipt of the remaining consents and approvals from regulators in Nevada, New Jersey and Indiana," said Tom Reeg, CEO of Eldorado.

13:00 EDT Baker Hughes reports U.S. rig count down 1 to 265 rigs

12:44 EDT Seneca Foods trading resumes

12:34 EDT Unilever halts Facebook, Twitter ads with 'much more to be done' on hate speech - Unilever (UN, UL) said in a statement: "We actively engaging with all digital platforms to make meaningful change and impact trust and transparency. We have made substantial progress, and we acknowledge the efforts of our partners, but there is much more to be done, especially in the areas of divisiveness and hate speech during this polarized election period in the U.S. The complexities of the current cultural landscape have placed a renewed responsibility on brands to learn, respond and act to drive a trusted and safe digital ecosystem. Given our Responsibility Framework and the polarized atmosphere in the U.S., we have decided that starting now through at least the end of the year, we will not run brand advertising in social media newsfeed platforms Facebook (FB), Instagram and Twitter (TWTR) in the U.S. Continuing to advertise on these platforms at this time would not add value to people and society. We will be monitoring ongoing and will revisit our current position if necessary. We will maintain our total planned media investment in the U.S. by shifting to other media." Shares of Facebook are down 7% to $219.10 and Twitter (TWTR) is down 7% to $29.18 in midday trading. Reference Link

12:20 EDT Facebook down 7% to $219.05 after Unilever joins others in halting ads

12:04 EDT Pfenex trading halted, news pending

12:00 EDT Everi Holdings falls -9.9% - Everi Holdings is down -9.9%, or -56c to $5.08.

12:00 EDT CoreLogic rises 24.4% - CoreLogic is up 24.4%, or $12.91 to $65.84.

12:00 EDT Gap rises 30.1% - Gap is up 30.1%, or $3.06 to $13.21.

11:45 EDT Chiasma trading halted, news pending

11:43 EDT Allegiant Travel to require customers to wear face masks during travel - Allegiant Travel announced that, beginning July 2, customers will be required to wear face masks during all phases of travel, including at the ticket counter, in the gate area, during boarding, on the aircraft and during the flight. This policy update builds on Allegiant's health and safety program by bringing an extra layer of protection to customers, crew and team members at Allegiant airports. "Since the onset of the pandemic, in concert with CDC guidance and medical experts, we have adopted a wide range of policies and procedures to ensure our customers can fly with confidence - from utilizing state-of-the art cleaning and disinfection technologies to providing complimentary Health and Safety Kits to all who travel with us," said Allegiant EVP and COO Scott Sheldon. "We have found that the vast majority of customers wear masks as a standard practice, but this update adds a layer of assurance and addresses customer needs as communities re-open. We had hoped to see a federal mandate to require face masks, so that all airlines could be uniform in their approach, to avoid customer confusion, and to aid enforcement. In the absence of that, we are taking this next needed step in our own policy."

11:29 EDT Overstock.com awarded a General Services Administration contract - Overstock.com has been awarded a General Services Administration Commercial e-Marketplace Acquisition contract, the GSA announced. Reference Link

10:32 EDT AIkido provides update on machine learning driven pancreatic cancer research - AIkido Pharma announced an update to its machine learning driven pancreatic cancer research. The company said: "As previously reported, the Company executed a Scientific Research Agreement with The University of Texas Southwestern Medical Center and Cogia BioTech to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. This work has recently identified 100 candidate markers of early and late stage pancreatic cancer, in human and preclinical models. Moving forward, the work will stage diagnostic markers, test prognostic indicators, and help identify drugs best suited for individual patient treatment." Anthony Hayes, CEO of AIkido, added: "Machine learning is an important contributor to this work and to the future of oncology drug development and treatment, and the research to date is encouraging. We hope this effort will help extend life for pancreatic cancer patients."

10:03 EDT Amazon launches 'Smart Stores' in India to enable local shops - The Day One Staff said in a post to the blog page earlier: "Amazon Pay announced the launch of "Smart Stores"; customers simply scan the store's QR code using the Amazon app to begin exploring the products available within the store. After selecting the products, they wish to buy they checkout with Amazon Pay, which gives them a choice of using UPI, balance, or credit or debit cards. Customers can on-the-spot convert a transaction into an EMI, and from time-to-time avail exciting rewards from their banks or through Amazon Pay. What's more - the bill is delivered digitally, making the entire journey contactless, convenient and rewarding.mazon Pay's Smart Store empowers local shops with the following capabilities to increase footfalls, improve customer experience and generate more sales. Digital Storefront: Enables a local shop to launch a digital storefront thereby enabling its customers to discover products, read reviews, evaluate offers while in the store or from anywhere using the Amazon app." Reference Link

10:00 EDT Big Lots rises 20.1% - Big Lots is up 20.1%, or $6.81 to $40.66.

10:00 EDT Gap rises 31.4% - Gap is up 31.4%, or $3.19 to $13.35.

09:47 EDT CIT Group falls -5.3% - CIT Group is down -5.3%, or -$1.16 to $20.67.

09:47 EDT Irsa Inversiones y Representaciones SA falls -6.5% - Irsa Inversiones y Representaciones SA is down -6.5%, or -22c to $3.14.

09:47 EDT CoreLogic rises 23.2% - CoreLogic is up 23.2%, or $12.26 to $65.19.

09:39 EDT Vaxart trading resumes

09:27 EDT Amazon confirms acquisition of self-driving car developer Zoox - Amazon and Zoox are announced that the companies have signed an agreement for Amazon to acquire Zoox. AMazon said in a statement: "Zoox is a forward-thinking team that is pioneering the future of ride-hailing by designing autonomous technology from the ground up with passengers front-of-mind. Aicha Evans, Zoox CEO, and Jesse Levinson, Zoox co-founder and CTO, will continue to lead Zoox as a standalone business as they innovate and drive towards their mission." "Zoox is working to imagine, invent, and design a world-class autonomous ride-hailing experience," said Jeff Wilke, Amazon's CEO, Worldwide Consumer. "Like Amazon, Zoox is passionate about innovation and about its customers, and we're excited to help the talented Zoox team to bring their vision to reality in the years ahead." Completion of this transaction is subject to customary closing conditions.

09:13 EDT Bristol-Myers, Acceleron announce EC approval of Reblozyl - Bristol-Myers (BMY) and Acceleron (XLRN) announced that the European Commission, or EC, has approved Reblozyl for the treatment of adult patients with transfusion-dependent anemia due to very low-, low- and intermediate-risk myelodysplastic syndromes, or MDS, with ring sideroblasts, who had an unsatisfactory response or are ineligible for erythropoietin-based therapy. The treatment was also approved for adult patients with transfusion-dependent anemia associated with beta thalassemia. Reblozyl is the first and only erythroid maturation agent approved in the European Union, representing a new class of therapy for eligible patients. This approval is based on data from the pivotal Phase 3 MEDALIST and BELIEVE studies, evaluating the ability of Reblozyl to effectively address anemia associated with MDS and beta thalassemia, respectively.

09:11 EDT American Airlines says flights to be 'booked to capacity' starting July 1 - American Airlines announced earlier: "As more people continue to travel, customers may notice that flights are booked to capacity starting July 1. American will continue to notify customers and allow them to move to more open flights when available, all without incurring any cost. This is in addition to the airline's current travel waivers...Any ticket for travel through Sept. 30, 2020, will not incur change fees prior to travel. Customers must pay any fare difference, if applicable, at time of ticketing of the new fare. Fare rules may apply depending on the ticket. All AAdvantage award tickets are included in this offer. Customers are allowed to change their origin and destination cities as part of this offer. Travel must be completed by Dec. 31, 2021." In addition, American announced that, beginning June 30, the airline will begin asking customers during the check-in process to certify that they have been free of COVID-19 symptoms for the past 14 days. American also announced that it is working with the Global Biorisk Advisory Council for GBAC STARTM Accreditation for its fleet of aircraft and customer lounges and that the company is creating a new Travel Health Advisory Panel, including Vanderbilt University Medical Center, to advise on health and cleaning matters as travelers return over the summer. Reference Link

09:09 EDT Synopsys broadens collaboration with EPFL - Synopsys announced it has broadened its ongoing academic collaboration by entering into an agreement to license novel digital synthesis technologies from EPFL, the Swiss Federal Institute of Technology in Lausanne, Switzerland.

09:07 EDT Tucson Electric Power sets target to reduce carbon emissions by 80% by 2035 - Fortis announced that its utility Tucson Electric Power in Arizona has set a target to reduce carbon emissions by 80% by 2035. Details of the clean energy targets are included in the utility's 2020 Integrated Resource Plan. Key elements of the Plan: 2,457 megawatts of new wind and solar power systems, including 457 MW that will be coming online over the next year; 1,400 MW of new energy storage systems; A proposal to ramp down and ultimately retire TEP's two units at the coal fired Springerville Generating Station in 2027 and 2032. The timeline would allow TEP to reduce the plant's workforce through attrition while providing time for the company to help the local community minimize the impact of the units' retirement; Eliminating the use of surface water for power generation and a 70% reduction in groundwater use; Continued support for energy efficiency programs to reduce usage and peak power demands. These changes will result in TEP avoiding more than 50 million tons of carbon dioxide emissions over the next 15 years. The Plan proposes reducing and ultimately eliminating its use of coal-fired resources. That transition is already underway, with the retirement of more than 600 MW of coal generation by June 2022 through recent and scheduled closures at the Navajo and San Juan Generating Stations. TEP also receives power from two coal-fired units at the Four Corners Generating Station that are scheduled to close in 2031. Concern about climate change and other environmental impacts, low natural gas prices and other factors created an opportunity to evaluate the long-term use of SGS Units 1 and 2. Though reliable, the usage of the coal-fired units will be reduced and the units eventually retired. Energy from SGS Units 1 and 2 will be replaced with increased energy from wind farms, solar arrays and energy storage systems. The Plan calls for a dramatic expansion of renewable energy resources, including some systems that are already under development. TEP is working to complete two large New Mexico wind farms and a local solar plus storage project that will more than double its community-scale clean energy resources by next year. The IRP also calls for enough new wind and solar generating capacity to provide more than 40% of the company's power in 2030, more than 60% by 2033 and more than 70% by 2035. The expansions coincide with the planned addition of energy storage systems, which are projected to cost significantly less after 2030 than they do today. TEP's CO2 emission reduction goal was developed in partnership with the University of Arizona's Institute of the Environment with input from a diverse group of customers, community leaders, local government representatives and environmental advocates, and is in line with the 2015 Paris Agreement to limit global warming to below 2 degrees Celsius. The Plan would reduce CO2 by 80% compared to 2005 levels. Plans for coal reduction at the SGS are subject to the Arizona Corporation Commission's approval of a modified plan for timely recovery of the plant's remaining value. TEP has not yet determined what rate changes it may request or the timing of any such request.

09:04 EDT Abbott reports new data from LightLab Initiative - Abbott announced new data from the company's LightLab Initiative that showed optical coherence tomography imaging significantly changes how physicians decide to treat a vessel compared to traditional angiography by providing physicians improved visualization within a patient's blood vessels. Data from the study revealed physicians altered their treatment strategy in 88% of coronary artery blockages based on new information provided by OCT. Using laser technology, OCT captures high-resolution images inside a patient's arteries, displaying the type and severity of disease in the vessel, as well as enabling more accurate measurements to determine how the patient should be treated.

09:04 EDT Verizon pauses Facebook ads pending 'acceptable solution' on hate speech - Verizon Chief Media Officer John Nitti said in a statement to media outlets: "We have strict content policies in place and have zero tolerance when they are breached, we take action. We're pausing our advertising until Facebook can create an acceptable solution that makes us comfortable and is consistent with what we've done with YouTube and other partners." According to Pathmatics, Verizon spent an estimated $406,600 in Instagram ads between May 22 and June 20, and spent $1.46M on Facebook in that same time period, CNBC reports. The move comes after the Anti-Defamation League said in an open letter that it found an advertisement for Verizon "appearing next to a video from the conspiracy group QAnon drawing on hateful and antisemitic rhetoric." Shares of Facebook are down 1%, or $2.43, to $233.25 in premarket trading. Reference Link

09:01 EDT Microsoft to change retail approach, sees 5c pre-tax charge in current quarter - Microsoft announced a strategic change in its retail operations, including closing Microsoft Store physical locations. The company's retail team members will continue to serve customers from Microsoft corporate facilities and remotely providing sales, training, and support. Microsoft will continue to invest in its digital storefronts on Microsoft.com, and stores in Xbox and Windows, reaching more than 1.2B people every month in 190 markets. The company will also reimagine spaces that serve all customers, including operating Microsoft Experience Centers in London, NYC, Sydney, and Redmond campus locations. The closing of Microsoft Store physical locations will result in a pre-tax charge of approximately $450M, or 5c per share, to be recorded in the current quarter ending June 30. The charge includes primarily asset write-offs and impairments.

08:46 EDT Invesco to close, liquidate Invesco RAFI Developed ex-US Small Company ETF - Invesco announced that it will close and liquidate the Invesco RAFI Strategic Developed ex-US Small Company ETF. In June, the Invesco ETF Board approved the liquidations. The last day of trading for the affected ETF on The Nasdaq Stock Market will be Monday, August 17. The last day creation orders will be accepted in the affected ETF will be Monday, August 10. Shareholders may sell their holdings of the affected ETF on Nasdaq until market close Monday, August 17. The affected ETF will no longer trade on Nasdaq after market close on Monday, August 17, and will be subsequently delisted. The final distribution to shareholders of the affected ETF is expected to occur on or about Monday, August 24.

08:43 EDT ZK International Group: Huaya partnership to increase production by ~$5.6M - The company said, "Earlier this month, we entered into an Exclusive Supplying and Distribution Framework Agreement with Shandong Huaye Group, a leading structural and fencing piping products manufacturer and suppliers in China. The Huaye Agreement covers Huaye's ongoing production line and machine upgrades as well as designating Huaye as the Company's strategic OEM manufacturer and distributor. The Upgrades, with Huaye's plan to allocate a total budget of approximately $49.7M, are now underway at Huaye's existing 120,000 square meters facility in Mengyin County, Shandong Province. ZK International is dispatching experienced engineers in support of the ongoing Upgrades which are expected to be completed by September 2020. Upon completion of the Upgrades, Huaye will become a designated OEM manufacturer and distributor of the full suite of ZK International's patented high-performance stainless steel and carbon steel piping products. Based on the current schedule for the Upgrades, we expect the Huaya Partnership to increase our total production output by up to approximately $5.6M in calendar year 2020, significantly ease our production capacity bottleneck and reduce our product delivery time. For over 18 years and with 500 distributors, Huaye has established itself as one of the leading manufacturers and suppliers of stainless steel structural and fencing piping products in the Northern and Eastern regions of China, particularly in Shandong Province. With complementary product portfolios and sales network, we have high hopes on the Huaye Partnership and expect it to bring us not only additional manufacturing capacity but also speedy access to the North Eastern China market where we have limited presence. Due to its price advantage, PPR pipe currently has higher market share than stainless steel pipe in North Eastern region of China. However, PPR pipes has high maintenance cost as a result of its significantly shorter life span compared to stainless steel pipes. Additionally, enhanced consumer health awareness helps stainless steel pipe rapidly gain larger market share. Currently we generate small percentage of revenues from North Eastern China region; leveraging Huaye's extensive sales channel, we anticipate that this region will become the fastest growing market for the coming years."

08:35 EDT Ryman Hospitality to reopen Grand Ole Opry, Ryman Auditorium for tours - Ryman Hospitality Properties provided the following business update: Colin Reed, Chairman and CEO of the Company, said, "As of today, Gaylord Opryland, Gaylord Palms, Gaylord Rockies and Gaylord Texan have all re-opened with revised operating standards and enhanced cleaning procedures. While very early in the re-opening process, the initial feedback from our guests at the Gaylord Texan, which re-opened on June 8, has been positive, and we are encouraged by its operating performance. Over its first 15 days of operations since re-opening, the Gaylord Texan generated an average occupancy of approximately 20%, with an average daily rate of approximately $190. The Gaylord Texan's initial weekend occupancy level was approximately 40%. While leisure transient occupancy generated over 95% of room demand in the first 15 days of Gaylord Texan's re-opening, small group meetings also accounted for approximately 300 of those room nights. We are also encouraged by the level of bookings for the summer period across all four of our re-opened hotels. At this time, we have not made a determination about the re-opening date for Gaylord National, given the current uncertainty regarding group demand and this hotel's primary focus as a convention hotel without a resort pool complex or other transient-focused amenities. We have experienced continued success in our group rebooking efforts across our Gaylord Hotels portfolio. Through June 24, 2020, we have experienced total attrition and cancellations of approximately 1.3 million net room nights, representing approximately $608M of total revenue, and we have successfully rebooked approximately 457,000 group room nights, representing approximately $208M in total revenue. Our existing Ole Red businesses in Tishomingo, Gatlinburg and Nashville have been open for several weeks at reduced capacities in accordance with applicable local and state health guidelines, and we opened our new Orlando Ole Red location on June 19. Nashville recently entered phase three of its four-phase re-opening plan, which allows for increased levels of operations at limited capacity in bars, restaurants and other venues. As a result, we intend to re-open the Grand Ole Opry and the Ryman Auditorium for tours today in accordance with the local health guidelines. We believe it is likely that these guidelines will continue to limit our ability to conduct concerts and other public events at the Grand Ole Opry and the Ryman Auditorium until at least early August. We are encouraged by early business levels and the response we have received from customers across our hospitality and entertainment portfolio related to the safety measures we have put in place, and we look forward to hosting additional guests in the weeks and months ahead. While we understand that COVID-19 will have a significant impact on our ability to return to business as usual for the foreseeable future, we are confident we have ample liquidity to weather an extended period of disruption, and we remain committed to continuing to control our expenses and adapting to the current business environment."

08:35 EDT LivePerson joins Google's partner program - LivePerson (LPSN) announced it has joined Google's (GOOG, GOOGL) partner program to help brands launch on Business Messages, which lets customers initiate messaging conversations with businesses directly from Google Search and Maps.

08:31 EDT Sarepta completes submission of NDA for casimersen in DMD - Sarepta Therapeutics announced the Company has completed the submission of a rolling New Drug Application to the U.S. Food and Drug Administration seeking accelerated approval for casimersen. Casimersen, a phosphorodiamidate morpholino oligomer, is engineered to treat patients with Duchenne muscular dystrophy who have genetic mutations that are amenable to skipping exon 45 of the Duchenne gene. The completion of the rolling submission includes data from the casimersen arm of the ESSENCE study, a global, randomized, double-blind, placebo-controlled Phase 3 study evaluating efficacy and safety in patients amenable to skipping exons 45 and 53. An interim analysis from ESSENCE demonstrated a statistically significant increase in dystrophin production as measured by western blot in patients who received casimersen compared to baseline and placebo. The study is ongoing, and remains blinded to collect additional efficacy and safety data. If the casimersen NDA is accepted and granted accelerated approval, the completed ESSENCE study will serve as a post-marketing confirmatory study.

08:26 EDT Privet, UPG issue letter to Synalloy stockholders in support of board nominees - Privet and UPG, which collectively own approximately 24.9% of the outstanding common stock of Synalloy, issued the below open letter in connection with its nomination of five independent candidates - Andee Harris, Chris Hutter, Aldo Mazzaferro, Ben Rosenzweig and John Schauerman - for election to Synalloy's board at the upcoming annual meeting of stockholders scheduled to be held on June 30. Privet and UPG said, "Privet Fund Management LLC (together with its affiliates, "Privet") and UPG Enterprises LLC (together with its affiliates, "UPG" and collectively with Privet, the "Stockholder Group" or "we" or "us") have maintained one overarching goal since the outset of this election contest: deliver the meaningful - not incremental - change urgently needed atop Synalloy Corporation ("Synalloy" or the "Company"). We nominated five highly-qualified individuals for election to the Company's eight-member Board of Directors (the "Board") because minority representation will not dislodge the incumbents, who have spent the last decade delivering staggering underperformance and racking up massive debt while failing to realize the potential of Synalloy's high-quality assets and skilled workforce. We believe the need for meaningful change at Synalloy has only grown in recent weeks as the Company has failed to produce a strategic turnaround plan and its stock has plunged to a near five-year low of $6.51 and has now been dropped from the Russell 3000. For Privet and UPG, this election contest has always been about putting qualified individuals in place who can address Synalloy's fixable weaknesses in the near-term and reposition the Company as a thriving public market participant over the long-term. This is why we released a detailed and transparent plan earlier this month that outlines revenue enhancement priorities, margin improvement initiatives and cost containment efforts. We continue to believe that immediate corrective action can ensure Synalloy averts financial distress, navigates any second wave of COVID-19 and delivers up to $25 per share in near-term value. Our plan also makes it abundantly clear that we are not seeking to acquire Synalloy in the future or initiate a so-called "integration" with UPG moving forward. Despite the incumbents' desperate attempts to divert attention from their lack of qualifications and objectively horrendous results, Privet and all of the Stockholder Group's nominees besides Chris Hutter have no financial stake in UPG. The Stockholder Group and its nominees would gain absolutely nothing from allowing any of Synalloy's value to accrue to another entity. We only make money when Synalloy's stock rises, and that has not happened under the incumbent Board... As this election contest has unfolded, we have been truly disappointed to see that the incumbent Board and Mr. Bram have resorted to what amount to dirty tricks and misinformation tactics. The Company has issued a press release nearly every day for the past week. Not a single one of these communications lays out what the incumbents stand for, how they plan to run the business or their long-term strategic vision. We cannot help but suspect that this approach - distractions and baseless mischaracterizations over business substance - has contributed to the massive erosion of stockholder value in recent weeks. Now that Synalloy's stock price is down more than 20% over the past 30 days, its market capitalization is roughly half of what it was just a year ago. This dire situation is compounded by the fact that Synalloy's debt now exceeds its equity market value and the Company appears destined to imminently breach its borrowing covenants. Bleak as all of this may seem, facilitating meaningful Board-level change at the Annual Meeting of Stockholders can be the remedy. Our nominees are ready to hit the ground running immediately and direct all of the Board's efforts towards prompt revenue enhancements, expedited cost cuts and immediate management of the Company's debt, including through leveraging Messrs. Rosenzweig and Hutter's relationships in the banking community to explore more favorable refinancing options. Mr. Hutter also intends to begin his tenure as interim Chief Executive Officer by traveling to all eight of Synalloy's businesses to meet with the first, second and third shift teams and managers. We will not waste any time engineering the wholesale turnaround that Synalloy clearly needs in order to avert financial distress and navigate the tremendous period of economic uncertainly that may ensue if COVID-19's second wave picks up. We hope all stockholders recognize that Privet, UPG and their nominees have not just invested capital in Synalloy, but also hundreds of hours of thoughtful planning and thorough preparation. When stockholders consider which slate offers the better people, plan and projected results, it should be clear that our slate is prepared to always go the extra mile for stockholders, employees, customers, vendors and the communities Synalloy operates in. We could not be more excited about the opportunity to build a stronger Synalloy that rewards stockholders and benefits all of the Company's stakeholders for years to come."

08:17 EDT HealthEquity appoints Tyson Murdock as deputy CFO, to succeed CFO Darcy Mott - HealthEquity announced that Tyson Murdock has been appointed EVP and Deputy CFO, effective July 1, 2020, and will succeed Darcy Mott as CFO April 1, 2021. Mr. Mott will continue in his current position as EVP and CFO through March 31, 2021 to ensure a smooth transition and completion of the fiscal year 2021 Form 10-K filing for the Company and will then transition into an advisory role to the CEO. Murdock joined HealthEquity in 2018 as SVP and Corporate Controller and brings 25 years of corporate finance experience to his new role as CFO.

08:09 EDT UK NHS, Medical College of Wisconsin and Yonsei University use Bionano Saphyr - Bionano Genomics announced that King's College Hospital London in the UK, the Medical College of Wisconsin, and Yonsei University Hospital, the leading South Korean University Hospital, have adopted the Saphyr system. The addition of Saphyr allows their scientists and clinicians to achieve comprehensive analysis of chromosomal aberrations and structural variations, including some that are unresolved by other current technologies, such as chromosomal microarray and next-generation sequencing technology. King's College Hospital London acquired the Saphyr system to perform a study on 210 leukemia patients. Their objective is to validate Saphyr's performance in digital cytogenetics, with the ultimate goal of replacing the use of standard cytogenetic methods in their laboratories with Bionano genome imaging altogether. King's College Hospital is the second NHS center to adopt Saphyr, after the NHS Lothian in Edinburgh, Scotland. The Medical College of Wisconsin plans to use Saphyr to expand their analyses on pediatric complex diseases beyond the copy number variants that can be detected with chromosomal microarray and add the balanced variants such as inversions and translocations that are missed by array. Yonsei University Hospital, one of the oldest and biggest university hospitals in South Korea, treats approximately 4,000,000 patients annually. They intend to use Saphyr to analyze the genomes of patients with various genetic diseases and cancer. As part of their initial validation of Saphyr, a patient with contradicting results generated by traditional cytogenetic methods of karyotyping and chromosomal microarray was analyzed. Saphyr identified the missed variant and detected additional specific gene-related structural variants that matched clinical findings and was not seen in previous results by any existing diagnostics tools.

08:06 EDT Cannae, Senator announce proposal to acquire CoreLogic for $65.00 per share - Cannae Holdings (CNNE) and Senator, which, directly or through affiliated entities, jointly own or have an economic interest equivalent to approximately 15% of the outstanding shares of CoreLogic (CLGX), sent a letter to the company's board of directors outlining a proposal to acquire CoreLogic for $65.00 per share in cash. The letter said, "We are writing to you on behalf of Cannae Holdings, Inc. and Senator Investment Group, LP (collectively, "we") which, directly or through our affiliated entities, jointly own or have an economic interest equivalent to approximately 15% of the outstanding common stock of CoreLogic, Inc. (the "Company"). We are pleased to submit this proposal to acquire the Company for $65.00 per share in cash, representing approximately $7 billion in total enterprise value. Senator firmly believes this proposal is in the best interest of all stakeholders and therefore has partnered with Cannae and its affiliates to help achieve this transaction by committing to support it from both a governance and financial perspective. Given our substantial equity stake in the Company, we are required to make the existence and contents of this letter public...We have followed the Company closely and have spent the last nine months performing extensive "outside-in" due diligence. Despite its strong market position as a provider of data and analytics for the real estate and mortgage industries, we believe the Company will not achieve its full potential under its current strategic plan. We therefore believe the proposed transaction is in the best interests of all the Company's stakeholders. Cannae and its affiliates in the proposed transaction are led by William P. Foley II (Bill Foley), a preeminent operator and investor with an established track record of successful acquisitions and value creation. Under Bill Foley's leadership, we would seek to reignite growth at CoreLogic, increase operating efficiency, and improve overall allocation of scarce capital resources. Bill Foley has extensive experience transforming similar businesses and is uniquely positioned to strengthen the Company's customer, financial, and employee relationships. We are offering a compelling premium to shareholders in cash at a time of considerable macroeconomic uncertainty. Our all-cash proposal represents a premium that is 37% in excess of the Company's unaffected stock price and 34% in excess of the Company's 30-day volume-weighted average price1. As one of the largest shareholders in the Company, we believe this proposal delivers full value to shareholders and is well in excess of what the Company can achieve under its current plans. This belief is demonstrated by the fact that we are offering shareholders, in a transaction we are prepared to close within a few months, a premium that is greater than the 26% share price appreciation it took the Company the past five years to accomplish. Cannae and its affiliates propose to acquire 100% of the outstanding shares of CoreLogic for $65.00 per share in an all-cash transaction. Cannae expects to finance the transaction and its related fees and expenses with a combination of equity investment that has already been spoken for in the amount of approximately $3.6 billion and third-party debt financing. Senator also expects to participate as an investor in the transaction. We are highly confident in our ability to secure the entirety of the debt financing required in connection with the transaction from a large national bank. Any definitive merger agreement that we may ultimately execute will not contain any financing contingencies. We expect that we would be able sign a definitive merger agreement and announce the transaction within one month after the Company provides access to relevant diligence materials... We are prepared to move quickly to reach signing of definitive agreements and believe that, once signed, we will be able to consummate the transaction within two to three months..."

08:05 EDT Agraflora Organics commences CBD cultivation at Binbrook Farm - AgraFlora Organics announced its wholly owned subsidiary Sustainable Growth Strategic Capital Corp. has entered into a cultivation partnership for hemp cultivation in Ontario. Pursuant to the Cultivation Partnership, SGSC has successfully planted fifty acres of high-quality hemp at a farm in Brinbrook Ontario. The Company anticipates the Binbrook Farm will yield approximately 50,000 kilograms of high CBD hemp in fall 2020. SGSC's cultivation partner, MicroC45 Inc. has a proprietary post-harvest mechanical separation process that results in higher extraction value and ultimately a greater yield of major and minor cannabinoids when extracted. Based on the forecasted yields and the proprietary nature of MicroC45's technology, the Company anticipates it will be able to create approximately 1,000 kgs of CBD isolate, CBD Distillate, and THC-Free Distillate inventory for sale to its current and future clients. Furthermore, the company announces it intends to complete a non-brokered private placement of up to 20,666,667 units of the company at a price of 7.5c per unit for gross proceeds of $2M. Each unit shall consist of one common share and one transferable share purchase warrant. Each warrant entitles the holder thereof to purchase one additional share of the company for a period of five years from closing at a price of 10c per share.

08:03 EDT T2 Biosystems announces granting of inducement award - T2 Biosystems announced that it issued inducement awards to four new employees. The awards were made on May 5, 2020 and June 2, 2020 under T2 Biosystems' Inducement Award Plan which was adopted on March 1, 2018 and amended and restated on January 8, 2020 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement award granted on May 5, 2020 consists of an option to purchase 3,000 shares of T2 Biosystems common stock and has a ten-year term. The exercise price of the option was $0.596 which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on May 5, 2020. The inducement awards granted on June 2, 2020 consist of options to purchase 9,500 shares of T2 Biosystems common stock and have a ten-year term. The exercise price of the options were $1.07 which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on June 2, 2020. The options vest in equal monthly installments over the four-year period following the grant date. The award was approved by the independent compensation committee of T2 Biosystems' board of directors and was granted as an inducement material to the new employee entering into employment with T2 Biosystems in accordance with Nasdaq Marketplace Rule 5635(c)(4).

08:02 EDT Cannae, Senator Investment propose to acquire CoreLogic for $65 per share, cash

08:01 EDT Passage Bio added to Russell 2000 Index - Passage Bio announced that it has been added to the Russell 2000 Index, effective as of market close today.

07:36 EDT Venus Concept joins Russell 2000, 3000 and Microcap indexes - Venus Concept announced that the Company has been added to the Russell 2000, Russell 3000 and Russell Microcap Indexes. The Company's inclusion in these indexes will become effective today after the US market close.

07:35 EDT Carvana launches online direct purchasing wholesale platform, CarvanaACCESS - Carvana announced yesterday that it has launched CarvanaACCESS, which it calls "a direct-purchase platform that gives independent and franchised dealers the ability to buy wholesale vehicles from Carvana." As consumer trade-ins and other wholesale vehicles are processed at Carvana locations across the country, they will be made available on CarvanaACCESS.com in a "timed bid" online auction enabled through a partnership with Manheim Digital, the company said. Scott Wood, senior director of wholesale operations at Carvana, added: "This direct purchase platform unlocks the full potential of Carvana's capabilities matched with technology modules from Manheim Digital, creating a whole new way to buy wholesale, directly from Carvana. We look forward to working with even more wholesale customers to provide them with our incredibly diverse inventory and national network."

07:32 EDT Helix BioPharma to divest remaining ownership of Polish subsidiary - Helix BioPharma announced that it has entered into a non-binding term sheet to divest the remaining shares it holds in its Polish subsidiary, Helix Immuno-Oncology, representing approximately 51% of the issued and outstanding shares of HIO prior to the HIO Private Placement. Under the term sheet, the Company has accepted a non-binding offer from CAIAC Fund Management AG, in its capacity as designated trustee of an Alternative Investment Fund, that is currently in the process of being established and authorized by the Financial Market Authority in Liechtenstein. The terms of the offer provide for Helix to sell its remaining holdings in HIO for gross proceeds of up to PLN6,700,000. The transaction is scheduled to close on August 31, 2020, and is subject to a number of conditions, including the approval of the Fund by the FMA; the raising of a minimum PLN7,300,000 by the Fund as well as regulatory approval of the transaction, if required. As a result, there can be no assurance that the closing of the Divestment will occur on the terms set out herein or at all. The Company has also approved an increase in share capital of HIO and the issuance of up to 2,200,000 Series B ordinary shares in the capital of HIO to enable it to issue up to 2,200,000 series B ordinary shares by way of a private placement financing for aggregate gross proceeds of approximately PLN 2,970,000. Assuming the successful completion of the HIO Private Placement, the Company's shareholding in HIO is expected to decrease to approximately 42.5 % of the outstanding shares of HIO. In addition, the Company has entered into agreements with HIO pursuant to which it has cancelled an aggregate amount of ~C$2,700,000 of intercompany debt owed to the Company by HIO. Since HIO is a subsidiary of the Company, the Consolidated Statements of Financial Position of the Company have not presented intercompany transactions as advances by the Company to HIO since liabilities of the subsidiary were offset and eliminated against each other on the Consolidated Statements of Financial Position. As part of the Debt Cancellation Agreements, the Company and HIO have agreed to terminate both the Biphasix asset transfer agreement and the V-DOS47 license agreement. As a result, all transferred assets related to Biphasix and V-DOS47 have been automatically re-assigned and transferred from HIO back to Helix without any formality. The Company has also ceased funding HIO with immediate effect. The debt forgiveness and the transfer of assets pursuant to the Debt Cancellation Agreement are considered related party transactions within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions. The Company relied on exemptions from the formal valuation and minority approval requirements in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of the transactions based on a determination that the fair market value of the transactions does not exceed 25% of the Company's market capitalization, as determined in accordance with MI 61-101.

07:08 EDT Keros Therapeutics to join Russell 2000 Index - Keros Therapeutics announced that the Company is set to join the Russell 2000 Index, effective after the close of the U.S. markets on June 26, 2020.

07:06 EDT Neuronetics appoints Bruce Shook to board of directors - Neuronetics announced the appointment of Bruce Shook to its Board of Directors and as a member of the Audit Committee effective immediately. Mr. Shook fills the seat vacated by Dr. Cheryl Blanchard. Neuronetics' Board of Directors will continue to have six members. Mr. Shook currently serves as Director, President and CEO for both Intact Vascular and Vesper Medical.

07:05 EDT Martin Midstream Partners enters restructuring support agreement - Martin Midstream Partners announced that it, its general partner, Martin Midstream GP LLC, and its subsidiaries Martin Midstream Finance Corp., Martin Operating GP LLC, Martin Operating Partnership L.P., Redbird Gas Storage LLC, Talen's Marine & Fuel, LLC and Martin Transport, Inc. have entered into a restructuring support agreement with holders that beneficially own over 62% in principal amount of the Partnership and FinanceCo's 7.25% Unsecured Notes due 2021. The Restructuring Support Agreement contemplates that the Partnership and FinanceCo will commence an out-of-court exchange offer to exchange Existing Notes for a combination of cash, 11.50% Senior Secured Second Lien Notes due 2025, and rights to acquire 10.00% Senior Secured 1.5 Lien Notes due 2024, subject to the terms and conditions of the Restructuring Support Agreement. In connection with the Exchange Offer, the Company will also commence a consent solicitation to make certain proposed amendments to the terms of the indenture governing the Existing Notes by eliminating or modifying certain restrictive covenants and other provisions. There are various closing conditions contemplated under the Restructuring Support Agreement including, among other things, the negotiation of definitive documentation and a minimum tender condition of 95% in principal amount of the Existing Notes in the Exchange Offer and consent solicitation. As an alternative to the Exchange Offer, the Company agreed in the Restructuring Support Agreement to solicit acceptances from eligible holders of the Existing Notes of a prepackaged plan of reorganization. In the event certain conditions to the Exchange Offer are not satisfied, and if a sufficient number of holders and amount of Existing Notes vote to accept the Prepackaged Plan, the Company intends to file petitions under chapter 11 of the U.S. Bankruptcy Code and pursue an in-court restructuring to implement the transactions contemplated herein. Pursuant to the Restructuring Support Agreement, the Supporting Holders have agreed to, among other things, support and use commercially reasonable efforts to complete the financial restructuring, including by tendering their Existing Notes in the Exchange Offer, delivering their consents in the related consent solicitation and voting in favor of the Prepackaged Plan. The Restructuring Support Agreement may be terminated by the Supporting Holders or the Company upon the occurrence of certain events enumerated in the Restructuring Support Agreement. In connection with the Restructuring Support Agreement and subject to agreement upon mutually acceptable definitive documentation, the Supporting Holders are agreeing to purchase any unsubscribed New Notes that have not been purchased by eligible holders in the rights offering as part of the Exchange Offer, or if the Exchange Offer and related Cash Tender Offer are not consummated, pursuant to the Prepackaged Plan. The purposes of the Exchange Offer and the issuance of the Exchange Notes and New Notes are to extend the maturities of the Company's indebtedness. The Company expects to continue the operation of its business in the ordinary course and does not anticipate interruption in its operations during the restructuring regardless of whether the Company conducts its restructuring in or out of the chapter 11 process. The transactions contemplated by the Restructuring Support Agreement are not intended to impact trade vendors, employees, customers, or any related contractual agreements or obligations. The Partnership's common units will remain outstanding and are not a part of the transactions contemplated by the Restructuring Support Agreement. The Company also expects to continue to have access to all necessary funds under its revolving credit facility, subject to the amendment of such revolving credit facility and receiving any related consents from its lenders.

07:01 EDT Mosaic files petitions to initiate countervailing duty investigations - Mosaic is filing petitions with the U.S. Department of Commerce and the U.S. International Trade Commission that request the initiation of countervailing duty investigations into imports of phosphate fertilizers from Morocco and Russia. As the largest U.S. producer of phosphate fertilizers, Mosaic took this action because large volumes of "unfairly subsidized" imports from Morocco and Russia are causing significant harm to Mosaic's operations. Mosaic's phosphate fertilizer business employs approximately 3,500 U.S. workers and operates mines and production facilities in Florida and processing plants in Louisiana.The company said, "The purpose of the petitions is to remedy the distortions that foreign subsidies are causing in the U.S. market for phosphate fertilizers, and thereby restore fair competition." The U.S. Department of Commerce and the U.S. International Trade Commission will consider the petitions and determine the next steps, which typically involve extensive administrative investigations. Mosaic intends to participate actively in those proceedings.

06:20 EDT Navistar appoints Persio Lisboa as CEO - Navistar announced that its board of directors has appointed Persio Lisboa president and CEO. Navistar said in a release, "Troy Clarke, who has held the roles of Navistar president, CEO and member of the board since April 2013 and chairman of the board since February 2017, will continue to serve the company in the newly created position of executive chairman. These changes are effective July 1. Lisboa joined Navistar in 1988 and has moved through the company's ranks, serving as executive vice president and COO since March 2017."

06:07 EDT Disney's Splash Mountain to be reimagined around 'The Princess and the Frog' - Disney Parks announced via Twitter: "We're thrilled to share Splash Mountain at Disneyland & Walt Disney World will be completely reimagined with a new story inspired by an all-time favorite film, "The Princess and the Frog." Reference Link

05:15 EDT DBV Technologies drops 14% to $4.63 after announcing restructuring

05:14 EDT Allergan, Molecular Partners receive CRL from FDA for Abicipar pegol BLA - Allergan, an AbbVie company, and Molecular Partners announced that the FDA has issued a Complete Response Letter, or CRL, to the Biologics License Application, or BLA, for Abicipar pegol, a novel, investigational DARPin therapy for patients with neovascular (wet) age-related macular degeneration, or nAMD. The companies said in a release, "The letter from the FDA indicates that the rate of intraocular inflammation observed following administration of Abicipar pegol 2mg/0.05 mL results in an unfavorable benefit-risk ratio in the treatment of neovascular (wet) age-related macular degeneration, or AMD. AbbVie plans to meet with the FDA to discuss their comments and determine next steps."

05:10 EDT Zogenix announces FDA approval of FINTEPLA - Zogenix announced that the FDA has approved FINTEPLA oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older. FINTEPLA will be launched through a restricted distribution program, called the FINTEPLA Risk Evaluation and Mitigation Strategy, or REMS, Program, and is expected to be available through Zogenix's specialty pharmacy partner by the end of July.